These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22959308)

  • 1. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.
    Mostoslavsky G
    Stem Cells; 2012 Jan; 30(1):28-32. PubMed ID: 21948613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
    Shafa M; Krawetz R; Rancourt DE
    Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
    Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
    Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells in medicine and biology.
    Takahashi K; Yamanaka S
    Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
    Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
    Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.